These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22000138)

  • 1. Prevention of cardiovascular disease in adult recipients of kidney transplants.
    Jardine AG; Gaston RS; Fellstrom BC; Holdaas H
    Lancet; 2011 Oct; 378(9800):1419-27. PubMed ID: 22000138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for and management of post-transplantation cardiovascular disease.
    Fellström B
    BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors determining cardiovascular disease progression after kidney transplant].
    Scolari MP; La Manna G; Cianciolo G; Cappuccilli ML; Lanci N; Donati G; Persici E; Cuna V; Feliciangeli G; Liviano D'Arcangelo G; Mosconi G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 46():30-43. PubMed ID: 19644816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk.
    Liefeldt L; Budde K
    Transpl Int; 2010 Dec; 23(12):1191-204. PubMed ID: 21059108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular complications of immunosuppressive agents in renal transplant recipients.
    Olyaei AJ; Demattos AM; Bennett WM
    Expert Opin Drug Saf; 2005 Jan; 4(1):29-44. PubMed ID: 15709896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cardiovascular risk factors after renal transplantation: a step towards reducing graft failure.
    Kumar R; Brar J; Yacoub R; Khan T; Zachariah M; Venuto R
    Transplant Proc; 2012 Jun; 44(5):1270-4. PubMed ID: 22663999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of kidney transplantation on the progression of cardiovascular disease.
    Satyan S; Rocher LL
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):274-93. PubMed ID: 15241742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the kidney transplant recipient.
    Padiyar A; Akoum FH; Hricik DE
    Prim Care; 2008 Sep; 35(3):433-50, v. PubMed ID: 18710663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors.
    Tinti F; Mitterhofer AP; Muiesan P
    Minerva Chir; 2012 Feb; 67(1):1-13. PubMed ID: 22361672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional and nontraditional cardiovascular risk factors and estimated risk for coronary artery disease in renal transplant recipients: a single-center experience.
    Banas MC; Banas B; Orth SR; Langer V; Reinhold SW; Weingart C; Jung B; Krüger B; Krämer BK
    Nephron Clin Pract; 2011; 119(3):c227-35. PubMed ID: 21849798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in recipients with kidney transplants from expanded criteria donors.
    Blanca L; Jiménez T; Cabello M; Sola E; Gutierrez C; Burgos D; Lopez V; Hernandez D
    Transplant Proc; 2012 Nov; 44(9):2579-81. PubMed ID: 23146460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy and life-style related diseases].
    Moriyama T
    Nihon Jinzo Gakkai Shi; 2008; 50(7):899-903. PubMed ID: 19069147
    [No Abstract]   [Full Text] [Related]  

  • 17. [Post-transplantation diabetes mellitus].
    Moreau K
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S71-6. PubMed ID: 17378145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of renal transplantation.
    Hashmi S; Poommipanit N; Kahwaji J; Bunnapradist S
    Minerva Med; 2007 Dec; 98(6):713-29. PubMed ID: 18299684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk profile for cardiovascular morbidity and mortality after lung transplantation.
    De Vito Dabbs A; Song MK
    Nurs Clin North Am; 2008 Mar; 43(1):37-53; vi. PubMed ID: 18249224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant.
    Taber DJ; Pilch NA; Meadows HB; McGillicuddy JW; Bratton CF; Chavin KD; Baliga PK; Egede LE
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):243-50. PubMed ID: 23258931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.